Literature DB >> 23017435

Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity.

Lotten Darlin1, Christer Borgfeldt, Ola Forslund, Emir Hénic, Joakim Dillner, Päivi Kannisto.   

Abstract

BACKGROUND: Several strategies have been used to reach non-attending women in organized cervical-cancer-screening programs, with varying success. Self-sampling (SS) for HPV is effective for increasing coverage in screening programs, but requires expensive commercial sampling kits.
OBJECTIVE: We aimed to evaluate if vaginal SS, without commercial preservatives was adequate for HPV testing. STUDY
DESIGN: Women with abnormal cervical smears as determined from the organized screening program were invited to a colposcopy clinic. The 121 women were asked to insert a cotton swab into the vagina and rotate it, put the cotton swab into a sterile cryotube, break the upper part of the stick and put the cap on. Thereafter, the gynaecologist collected a liquid based cytology (LBC) sample. The presence of HPV-types in SS and LBC samples was analysed with PCR and luminex-based typing.
RESULTS: High-risk-HPV (hr-HPV) DNA was found in 65 of the tested 108 SS (60%; 95% CI 0.50-0.69), whereas LBC found hr-HPV in 64/108 samples (59%; 95% CI 0.49-0.69). The agreement between sampling with SS and LBC was good, kappa value 0.67 (95% CI; 0.53-0.81). The sensitivity for SS with hr-HPV to find HSIL was 77% (95% CI; 62-91%), specificity 47% (95% CI; 35-59%) [corrected] and the sensitivity for LBC with hr-HPV to find HSIL was 79% (95% CI 66-93%), specificity 50% (95% CI; 38-62%). [corrected]
CONCLUSIONS: This new vaginal self-sampling method detects hr-HPV-infections with similar sensitivity as a cervical smear taken by a gynaecologist. This self-sampling method is cost-effective and well tolerated, and the kit is suitable for regular mail transport.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23017435     DOI: 10.1016/j.jcv.2012.09.002

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  High-risk Human Papillomavirus Messenger RNA Testing in Wet and Dry Self-collected Specimens for High-grade Cervical Lesion Detection in Mombasa, Kenya.

Authors:  Jessica Yasmine Islam; Michael M Mutua; Emmanuel Kabare; Griffins Manguro; Michael G Hudgens; Charles Poole; Andrew F Olshan; Stephanie B Wheeler; R Scott McClelland; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2020-07       Impact factor: 3.868

2.  Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.

Authors:  Pedro Surriabre; Gustavo Allende; Marcela Prado; Leyddy Cáceres; Diego Bellot; Andrea Torrico; Karina Ustariz; Shirley Rojas; Jaime Barriga; Pamela Calle; Ligia Villarroel; Rosse Mary Yañez; Marc Baay; Patricia Rodriguez; Véronique Fontaine
Journal:  BMC Womens Health       Date:  2017-12-22       Impact factor: 2.809

3.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Authors:  Marc Arbyn; Sara B Smith; Sarah Temin; Farhana Sultana; Philip Castle
Journal:  BMJ       Date:  2018-12-05

4.  Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.

Authors:  Teodora Bokan; Urska Ivanus; Tine Jerman; Iztok Takac; Darja Arko
Journal:  Radiol Oncol       Date:  2021-01-06       Impact factor: 2.991

5.  Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial.

Authors:  K Haguenoer; S Sengchanh; C Gaudy-Graffin; J Boyard; R Fontenay; H Marret; A Goudeau; N Pigneaux de Laroche; E Rusch; B Giraudeau
Journal:  Br J Cancer       Date:  2014-09-23       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.